| Menopause |
1 |
1 |
| Breast Cancer |
0 |
1 |
| Breast Cancer Family History |
0 |
0.71 |
| Breast Cancer History |
0 |
0.7 |
| Cancer |
0 |
0.59 |
| Breast |
0 |
0.57 |
| Cancer Risk |
0 |
0.56 |
| Colorectal Cancer |
0 |
0.45 |
| Colon Cancer |
0 |
0.44 |
| Estrogen |
0 |
0.38 |
| Thyroid Disease |
0 |
0.38 |
| Thyroid Cancer |
0 |
0.37 |
| Transdermal |
0 |
0.32 |
| Hypertension |
0 |
0.29 |
| Selective Estrogen Receptor Modulators |
0 |
0.23 |
| Obesity |
0 |
0.17 |
| Thromboembolism |
0 |
0.13 |
| Cardiovascular Risk Management |
0 |
0.12 |
| Blood |
0 |
0.1 |
| Lipids Management |
0 |
0.1 |
| Venous Thromboembolism (VTE) |
0 |
0.08 |
| Body Mass Index |
0 |
0.07 |
| Coronary Artery Disease (CAD) |
0 |
0.07 |
| Quality of Life |
0 |
0.07 |
| Type 2 Diabetes Mellitus |
0 |
0.07 |
| Uterus |
0 |
0.07 |
| Hypothyroidism |
0 |
0.06 |
| Night Sweats |
0 |
0.06 |
| Selective Serotonin-Reuptake Inhibitors |
0 |
0.06 |
| Clinical Guidelines |
0 |
0.05 |
| Cognitive Behavioral Therapy |
0 |
0.05 |
| Heart |
0 |
0.05 |
| Off-Label Use |
0 |
0.05 |
| Sleep |
0 |
0.05 |
| Weight Management |
0 |
0.05 |
| Adverse Effects |
0 |
0.03 |
| Bone |
0 |
0.03 |
| Cardiovascular disease |
0 |
0.03 |
| Cerebrovascular Accident |
0 |
0.03 |
| Chronic Disease |
0 |
0.03 |
| Contraception |
0 |
0.03 |
| Controlled Hypertension |
0 |
0.03 |
| Diabetes Mellitus |
0 |
0.03 |
| Endocrine Society |
0 |
0.03 |
| Fractures |
0 |
0.03 |
| Ganglion |
0 |
0.03 |
| Hormonal Therapy |
0 |
0.03 |
| Hypnosis |
0 |
0.03 |
| Hypothyroidism History |
0 |
0.03 |
| Liver |
0 |
0.03 |
| Metabolism |
0 |
0.03 |
| Patient Safety |
0 |
0.03 |
| Progestin |
0 |
0.03 |
| Shared Decision-Making |
0 |
0.03 |
| Stress |
0 |
0.03 |
| Thyroid |
0 |
0.03 |
| Triglycerides |
0 |
0.03 |
| Vagina |
0 |
0.03 |
| Weight Gain |
0 |
0.03 |
| Weight Loss |
0 |
0.03 |